Otiato, M.; Moghaddam, F.S.; Ghoreifi, A.; Autorino, R.; Bignante, G.; Sundaram, C.; Sidhom, D.; Derweesh, I.H.; Puri, D.; Margulis, V.;
et al. Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group. Cancers 2025, 17, 2144.
https://doi.org/10.3390/cancers17132144
AMA Style
Otiato M, Moghaddam FS, Ghoreifi A, Autorino R, Bignante G, Sundaram C, Sidhom D, Derweesh IH, Puri D, Margulis V,
et al. Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group. Cancers. 2025; 17(13):2144.
https://doi.org/10.3390/cancers17132144
Chicago/Turabian Style
Otiato, Maxwell, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, Riccardo Autorino, Gabriele Bignante, Chandru Sundaram, Daniel Sidhom, Ithaar H. Derweesh, Dhruv Puri, Vitaly Margulis,
and et al. 2025. "Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group" Cancers 17, no. 13: 2144.
https://doi.org/10.3390/cancers17132144
APA Style
Otiato, M., Moghaddam, F. S., Ghoreifi, A., Autorino, R., Bignante, G., Sundaram, C., Sidhom, D., Derweesh, I. H., Puri, D., Margulis, V., Popokh, B., Abdollah, F., Stephens, A., Ferro, M., Simone, G., Tuderti, G., Mehrazin, R., Eraky, A., Gonzalgo, M.,
... Djaladat, H.
(2025). Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group. Cancers, 17(13), 2144.
https://doi.org/10.3390/cancers17132144